• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX SETS (ST); DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX SETS (ST); DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 107640
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Fungal Infection (2419)
Event Type  Injury  
Manufacturer Narrative
Prismaflex st150 set has been temporarily approved for use in the us under emergency use authorization eua200704 to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.The device was discarded and the lot number is unknown; therefore, a device analysis could not be completed, however, based on the information receive the cause of the reported condition is user related.The function of dialysis is to filter blood.As per prismaflex st150 set instruction for use (ifu): ¿since drugs can pass through the membrane of the filter, the dosage of associated drug treatments must be adjusted for patients on continuous renal replacement therapy¿.This is a known effect of the device that would have been mitigated by appropriate dosage adjustment of ambisome by the clinician.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that a patient experienced ¿ineffectiveness of treatment following the establishment of an extra-renal purification following the appearance of an acute kidney injury" and invasive candidiasis.The patient was performing continuous veno-venous hemodiafiltration (cvvhdf) using a prismaflex st150.The patient was transferred to the intensive care unit and treated with axepim 2g x 2/d, flagyl 500 mg x3/d, ambisome (5 then 3 mg/kg/d (210 mg/d) continuously and uninterrupted for 67 days), lasix, morphine titration and cortancyl 80 mg/d.The patient was intubated and was provided hemodynamic support with noradrenaline and dobutamine.It was not reported if the patient recovered om the invasive candidiasis event.No additional information were provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX SETS (ST)
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - MEYZIEU
7, av lionel terray, b.p. 126
meyzieu cedex rhone 69883
FR   69883
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 
2242702068
MDR Report Key15638905
MDR Text Key302074440
Report Number8010182-2022-00316
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number107640
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/23/2022
Initial Date FDA Received10/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient SexMale
-
-